A new designer drug 5F-ADB activates midbrain dopaminergic neurons but not serotonergic neurons
Author:
Affiliation:
1. Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University
Publisher
Japanese Society of Toxicology
Subject
Toxicology
Link
https://www.jstage.jst.go.jp/article/jts/41/6/41_813/_pdf
Reference16 articles.
1. Asaoka, N., Nagayasu, K., Nishitani, N., Yamashiro, M., Shirakawa, H., Nakagawa, T. and Kaneko, S. (2015): Olanzapine augments the effect of selective serotonin reuptake inhibitors by suppressing GABAergic inhibition via antagonism of 5-HT6 receptors in the dorsal raphe nucleus. Neuropharmacology, 95, 261-268.
2. Banister, S.D., Longworth, M., Kevin, R., Sachdev, S., Santiago, M., Stuart, J., Mack, J.B., Glass, M., McGregor, I.S., Connor, M. and Kassiou, M. (2016): Pharmacology of valinate and tert-leucinate synthetic cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and their analogues. ACS Chem. Neurosci. [Epub ahead of print]
3. Bijl, D. (2004): The serotonin syndrome. Neth. J. Med., 62, 309-313.
4. Castellanos, D. and Gralnik, L.M. (2016): Synthetic cannabinoids 2015: An update for pediatricians in clinical practice. World J. Clin. Pediatr., 5, 16-24.
5. Geddes, S.D., Assadzada, S., Lemelin, D., Sokolovski, A., Bergeron, R., Haj-Dahmane, S. and Béïque, J.C. (2016): Target-specific modulation of the descending prefrontal cortex inputs to the dorsal raphe nucleus by cannabinoids. Proc. Natl. Acad. Sci. USA, 113, 5429-5434.
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Analytical findings in a non-fatal intoxication with the synthetic cannabinoid 5F-ADB (5F-MDMB-PINACA): a case report;International Journal of Legal Medicine;2021-12-18
2. Pharmacology and adverse effects of new psychoactive substances: synthetic cannabinoid receptor agonists;Archives of Pharmacal Research;2021-04
3. Advances in D-Amino Acids in Neurological Research;International Journal of Molecular Sciences;2020-10-03
4. Designer drugs: a medicinal chemistry perspective (II);Annals of the New York Academy of Sciences;2020-05-12
5. How preclinical studies have influenced novel psychoactive substance legislation in the UK and Europe;British Journal of Clinical Pharmacology;2020-02-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3